Back to Search Start Over

Metformin-Induced Generalized Bullous Fixed-Drug Eruption with a Positive Dechallenge-Rechallenge Test: A Case Report and Literature Review

Authors :
Bahareh Abtahi-Naeini
Tooba Momen
Rezvan Amiri
Parvin Rajabi
Fereshte Rastegarnasab
Source :
Case Reports in Dermatological Medicine, Vol 2023 (2023)
Publication Year :
2023
Publisher :
Hindawi Limited, 2023.

Abstract

Metformin is a commonly used medication in diabetic patients. It can cause different complications including cutaneous adverse reactions. Metformin-induced fixed-drug eruption (FDE) has been reported in limited cases. Due to the popularity of metformin, clinicians need to be aware of uncommon drug reactions for proper diagnosis and treatment. Herein, we report a 43-year-old man with generalized bullous lesions with a positive dechallenge-rechallenge test diagnosed as metformin-induced generalized bullous fixed-drug eruption. Metformin dosage was stopped and lesions were treated with topical clobetasol propionate and oral prednisolone and cyclosporine-A. After a 6-month follow-up, he was well without any relapsing episodes.

Subjects

Subjects :
Dermatology
RL1-803

Details

Language :
English
ISSN :
20906471
Volume :
2023
Database :
Directory of Open Access Journals
Journal :
Case Reports in Dermatological Medicine
Publication Type :
Academic Journal
Accession number :
edsdoj.fa096edb7bd441f6925eee373e1eae47
Document Type :
article
Full Text :
https://doi.org/10.1155/2023/6353919